Penserra Capital Management’s Viking Therapeutics VKTX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$55K	Sell	2,105 -167	-7%	-$4.36K	﹤0.01%	759
2025 Q1	$54K	Buy	2,272 +206	+10%	+$4.9K	﹤0.01%	845
2024 Q4	$83K	Buy	2,066 +192	+10%	+$7.71K	﹤0.01%	881
2024 Q3	$118K	Buy	1,874 +583	+45%	+$36.7K	﹤0.01%	767
2024 Q2	$68K	Buy	+1,291	New	+$68K	﹤0.01%	842